Profile: BTG PLC (BTG.L)

BTG.L on London Stock Exchange

568.00GBp
5 Feb 2016
Change (% chg)

4.50p (+0.80%)
Prev Close
563.50p
Open
568.00p
Day's High
575.00p
Day's Low
568.00p
Volume
640,538
Avg. Vol
688,939
52-wk High
813.50p
52-wk Low
504.00p

Search Stocks
BTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). The Company's Interventional Medicine segment offers a portfolio of interventional medicine products that are designed to advance the treatment of liver tumors, advanced emphysema, severe blood clots and varicose veins. The Company's Specialty Pharmaceuticals segment offers a portfolio of antidote products that alleviate toxicity and treat rare conditions. The Company's Licensing segment receives royalties relating to the sales of products that are subject to intellectual property and license agreements between the Company and various partners. The Company's subsidiaries include BTG International (Holdings) Ltd, Provensis Ltd, BTG International Ltd and BTG Employee Share Schemes Ltd, among others.

Company Address

BTG PLC

5 Fleet Place
LONDON     EC4M 7RD
P: +4420.75750000
F: +4420.75750010

Company Web Links

Search Stocks